CC-8490

· Celgene Corporation

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for CC-8490, covering 2007-01-04 to 2015-04-30. Get the full timeline:

Most recent: Clinical Trial Update: CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas [Phase 1]